These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9789505)
41. HIV prevention case management is not cost-effective. Cohen DA; Wu SY; Farley TA Am J Public Health; 2006 Mar; 96(3):400-1; author reply 401. PubMed ID: 16449573 [No Abstract] [Full Text] [Related]
42. Comment: cost-effective pharmaceutical care for HIV disease. Hoar ME Ann Pharmacother; 1998 Jun; 32(6):716-7. PubMed ID: 9640494 [No Abstract] [Full Text] [Related]
43. The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination. Bloch M; Carr A; Vasak E; Cunningham P; Smith D Am J Obstet Gynecol; 1999 Sep; 181(3):760-1. PubMed ID: 10486500 [TBL] [Abstract][Full Text] [Related]
44. Research. Daily antiretroviral treatment shown to prevent HIV infections in MSM. AIDS Policy Law; 2011 Jan; 26(2):1, 4. PubMed ID: 21344685 [No Abstract] [Full Text] [Related]
45. Antiretroviral prophylaxis after recent sexual exposure to HIV. Sadovsky R Am Fam Physician; 1998 Aug; 58(2):539-40. PubMed ID: 9713403 [No Abstract] [Full Text] [Related]
46. The care of persons with recent sexual exposure to HIV. Katz MH; Gerberding JL Ann Intern Med; 1998 Feb; 128(4):306-12. PubMed ID: 9471935 [TBL] [Abstract][Full Text] [Related]
47. Should preventive antiretroviral treatment be offered following sexual exposure to HIV? Not yet! Evans B; Darbyshire J; Cartledge J Sex Transm Infect; 1998 Apr; 74(2):146-8. PubMed ID: 9634331 [No Abstract] [Full Text] [Related]
48. Postexposure treatment of HIV. Li RW; Wong JB N Engl J Med; 1997 Aug; 337(7):499-500; author reply 501. PubMed ID: 9254337 [No Abstract] [Full Text] [Related]
49. HIV prevention in serodiscordant pair. Winslow DL AIDS Alert; 2011 Oct; 26(10):116-7. PubMed ID: 22096786 [No Abstract] [Full Text] [Related]
50. Prophylaxis after HIV exposure. Legg J Am Fam Physician; 1997 Oct; 56(6):1574, 1577-8. PubMed ID: 9351425 [No Abstract] [Full Text] [Related]
51. Prophylaxis after sexual exposure to HIV. Frothingham R Ann Intern Med; 1998 Oct; 129(8):671-2. PubMed ID: 9786826 [No Abstract] [Full Text] [Related]
52. Targeted HIV treatment to sex workers to promote HIV prevention. Cameron DW J Int Assoc Physicians AIDS Care (Chic); 2002; 1(2):51-2. PubMed ID: 12942676 [No Abstract] [Full Text] [Related]
53. Postexposure prophylaxis following HIV exposure. Kahn JG; Pinkerton SD; Paltiel AD JAMA; 1999 Apr; 281(14):1269-70. PubMed ID: 10208135 [No Abstract] [Full Text] [Related]
54. Should preventive antiretroviral treatment be offered following sexual exposure to HIV? The case for. Desmond NM; Coker RJ Sex Transm Infect; 1998 Apr; 74(2):144-5. PubMed ID: 9634330 [No Abstract] [Full Text] [Related]
55. Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection. Derdelinckx I; Wainberg MA; Lange JM; Hill A; Halima Y; Boucher CA PLoS Med; 2006 Nov; 3(11):e454. PubMed ID: 17090213 [TBL] [Abstract][Full Text] [Related]
56. Sexual networks and HIV. Morris M AIDS; 1997; 11 Suppl A():S209-16. PubMed ID: 9451987 [No Abstract] [Full Text] [Related]
57. HIV programmes reduce deaths and new infections, UNAIDS report shows. Roehr B BMJ; 2008 Aug; 337():a1099. PubMed ID: 18676440 [No Abstract] [Full Text] [Related]
58. AZT to cost less. Ohio Med; 1989 Dec; 85(12):932. PubMed ID: 2594307 [No Abstract] [Full Text] [Related]
59. Is HIV prophylaxis effective for sexual exposures? Vanchieri C Ann Intern Med; 1998 Mar; 128(6):513-4. PubMed ID: 9499350 [No Abstract] [Full Text] [Related]
60. Cost effectiveness of treating asymptomatic HIV infection. Hamilton JD; Simberkoff MS; Hartigan PM Ann Intern Med; 1991 Oct; 115(8):655-6. PubMed ID: 1909849 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]